Moderate to severe atopic dermatitis Trials in Miami, United States
Conditions / Moderate to severe atopic dermatitis / Miami, United States
Research into Moderate to severe atopic dermatitis spans multiple therapeutic approaches and trial phases.
10 total trials for this combination
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT03568162 | Phase 2b Study to Evaluate the Efficacy and Safety of ISB 830 in Adults With Moderate to Severe Atopic Dermatitis | COMPLETED | PHASE2 |
| NCT05899816 | A Study Assessing Rocatinlimab on Vaccine Antibody Response in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET - VOYAGER) | COMPLETED | PHASE3 |
| NCT05984784 | A Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of IMG-007 in Adults With Atopic Dermatitis (AD) | TERMINATED | PHASE1/PHASE2 |
| NCT03985943 | Efficacy and Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis | COMPLETED | PHASE3 |
| NCT06136741 | A Phase 2b Study to Evaluate Rezpegaldesleukin (Rezpeg) in the Treatment of Adult Patients With Moderate-to-Severe Atopic Dermatitis | ACTIVE_NOT_RECRUITING | PHASE2 |
| NCT03989206 | Long-term Safety and Efficacy of Nemolizumab With Moderate-to-severe Atopic Dermatitis | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT04444752 | A Study to Assess the Efficacy and Safety of CBP-201 in Adult Subjects With Moderate to Severe Atopic Dermatitis | COMPLETED | PHASE2 |
| NCT05203380 | Neuropsychologic Assessments of Dupilumab-Treated Adolescent Participants With Moderate-to-Severe Atopic Dermatitis | COMPLETED | — |
| NCT05590585 | Dupilumab in Adolescent and Adult Skin of Color Participants: Open-label Moderate-to-severe Eczema Trial | COMPLETED | PHASE4 |
| NCT03989349 | Efficacy & Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis | COMPLETED | PHASE3 |